-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Today (April 11), the official website of the National Medical Products Administration (NMPA) of China announced that Pfizer’s oral JAK1 inhibitor abrocitinib (abrocitinib, the Chinese brand name is Cipike) has been approved in China.
Abraxitinib is a once-daily oral JAK1 inhibitor that is part of Pfizer's global pipeline of JAK inhibitors